false 0001635077 0001635077 2025-07-21 2025-07-21 0001635077 ACON:CommonStockParValue0.00001PerShareMember 2025-07-21 2025-07-21 0001635077 ACON:WarrantsEachExercisableForOneShareOfCommonStockMember 2025-07-21 2025-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 21, 2025

 

 

 

Aclarion, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-41358 47-3324725
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

8181 Arista Place, Suite 100  
Broomfield, Colorado 80021
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (833) 275-2266

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

  Trading  
Title of each class Symbol(s) Name of each exchange on which registered
Common Stock ACON Nasdaq Stock Market
Common Stock Warrants ACONW Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On July 21, 2025, the Company reconvened and held its 2025 Annual Meeting of Stockholders. The Annual Meeting had been adjourned from the original scheduled meeting date of July 7, 2025.

 

The matters voted upon at the Annual Meeting and the results of such voting are set forth below.

 

Proposal 1 - Election of seven directors to serve a term ending at the 2026 annual meeting, in each case until their respective successors are duly elected and qualified.

 

Nominee  Votes For  Withheld  Broker Non-Votes
Jeffrey Thramann   51,347    15,267    200,431 
Brent Ness   47,840    18,774    200,431 
Stephen Deitsch   47,374    19,240    200,431 
Scott Breidbart   50,170    16,444    200,431 
David Neal   49,956    16,658    200,431 
William Wesemann   49,902    16,713    200,431 
Amanda Williams   50,244    16,370    200,431 

 

All seven director nominees were duly elected.

 

 

Proposal 2 - Ratification of appointment of independent registered accounting firm – Haynie & Company

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 241,005    23,143    2,898    0 

 

Proposal 2 was approved.

 

 

Proposal 3 – Approval of a proposed reverse stock split

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 177,593    87,330    2,124    0 

 

Proposal 3 was approved.

 

 

Proposal 4 – Approval of an amendment to our 2022 equity incentive plan

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 29,621    35,466    1,527    200,431 

 

Proposal 4 was not approved.

 

 

 

 

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ACLARION, INC.
     

July 21, 2025

By:/s/ John Lorbiecki
  Name: John Lorbiecki
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 3